Stay updated with breaking news from Based Compensation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Q2 2023 YUPELRI® (revefenacin) net sales of $55.0 million, recognized by Viatris, up 12% from Q2 20221 Q2 2023 YUPELRI total retail TRx and new to product TRx...
/PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK) (the "Company"), a premier partner for transformative brands, digital media and marketing companies, today...
Total revenue of $75.8 million, up 11% year-over-year. Subscription revenue of $57.3 million, up 14% year-over-year. Subscription gross margin of 75% and non-GAAP subscription gross margin...
STATEMENT OF EXECUTIVE COMPENSATION FOR THE YEAR-ENDED APRIL 30, 2023 Table of Contents COMPENSATION...
STOCK OPTION PLAN PART 1 DEFINITIONS 1.01Definitions In this Plan the following words and phrases shall have the following meanings, namely: ...